Latest Industry Insights

Technology Networks spoke to Francisco Bizouarn, market development manager of the Digital Biology Group at Bio-Rad Laboratories, to find out how wastewater testing works and how it can anticipate a rise in cases of COVID-19 and the emergence of new variants.

Learn how automation can help to obtain high-quality next generation sequencing research data.

In this interview, Lei Zhou, PhD, head of the Ocular Proteomics Platform at the Singapore Eye Research Institute, talks about the development of a novel diagnostic test to guide precision medicine to prevent dry eye in patients after laser eye surgery.

Research is advancing exciting areas of science at an unprecedented pace, but the disposable materials, powered equipment and shipping associated with experiments, sample storage and transport of reagents contribute to high energy consumption and significant waste. How are researchers bringing sustainability to scientific discovery?

In April 2022, Cancer Research UK unveiled Cancer Research Horizons, its new approach to driving innovation in the field. Technology Networks had the opportunity to speak with two members of Cancer Research Horizon’s executive leadership team to learn more about some of the cutting-edge experimental capabilities that will be used to interrogate cancer biology more thoroughly.

This article takes a look at the incredible transformation high performance computing has experience over the past few years.

We spoke to Geoff Winkett and Michel van den Berge from Agilent, about the concerns they hear from their customers in the pharmaceutical and biopharmaceutical sector and how they are helping to address them.

In research and healthcare, use of the right choice of data capture technique is key. A data registry approach is one such method. Dr. Steven Labkoff, global head of clinical & healthcare informatics at the registry science practice Quantori, is a pioneer in the field. In this interview, we discuss use cases for registries and how they compare to electronic health record based (EHR) approaches.

Technology Networks spoke to Jason Ornstein and Barry Holtz to learn how Synshark and Phylloceuticals are working together to address current challenges associated with squalene supply and access.

In this opinion piece, Dan Gibson discusses some of the common pitfalls in the DNA synthesis field and explores how a new generation of synthesis technologies could overcome these challenges.